RORI BRIDGES: Open Payments
NPI 1114170529 · FOREST, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 10 payments from 7 companies in 2025. Trend: 2023 $115 · 2024 $54 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| Lilly USA, LLC | 1 | $28 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Organon LLC | 1 | $6 |
Products named: Veozah, GEMTESA, ZEPBOUND, TRINTELLIX, Mirena, MYFEMBREE, NEXPLANON.
Industry payments across MS — which companies pay providers there.
